Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Debing

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Antiviral Research|July 14, 2023
Establishment of a robust rat hepatitis E virus fecal-oral infection model and validation for antiviral studiesXin Zhang, Niels Cremers, Stijn Hendrickx, et al.
Gastroenterology|September 3, 2014
A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipientsYannick Debing, Anett Gisa, Kai Dallmeier, et al.
Scientific Reports|May 4, 2022
AAV9-mediated functional screening for cardioprotective cytokines in Coxsackievirus-B3-induced myocarditisPaolo Carai, Giulia Ruozi, Alexandra Paye, et al.
Antiviral Research|March 9, 2013
3',5'Di-O-trityluridine inhibits in vitro flavivirus replicationTine De Burghgraeve, Barbara Selisko, Suzanne Kaptein, et al.
Journal of Hepatology|December 3, 2015
Stem cell-derived hepatocytes: A novel model for hepatitis E virus replicationNicky Helsen, Yannick Debing, Jan Paeshuyse, et al.
JHEP Reports : Innovation in Hepatology|October 10, 2024
CAM-A-dependent HBV core aggregation induces apoptosis through ANXA1Valerio Taverniti, Laura Meiss-Heydmann, Cloé Gadenne, et al.
Journal of Hepatology|May 14, 2016
Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivityYannick Debing, Christophe Ramière, Kai Dallmeier, et al.
Gastroenterology|March 4, 2014
Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virusYijin Wang, Xinying Zhou, Yannick Debing, et al.
Antiviral Research|January 13, 2017
Biological or pharmacological activation of protein kinase C alpha constrains hepatitis E virus replicationWenshi Wang, Yijin Wang, Yannick Debing, et al.
Gut|March 24, 2016
Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liverIbrahim M Sayed, Lieven Verhoye, Laurence Cocquerel, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Antiviral Research|July 14, 2023
Establishment of a robust rat hepatitis E virus fecal-oral infection model and validation for antiviral studiesXin Zhang, Niels Cremers, Stijn Hendrickx, et al.
Gastroenterology|September 3, 2014
A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipientsYannick Debing, Anett Gisa, Kai Dallmeier, et al.
Scientific Reports|May 4, 2022
AAV9-mediated functional screening for cardioprotective cytokines in Coxsackievirus-B3-induced myocarditisPaolo Carai, Giulia Ruozi, Alexandra Paye, et al.
Antiviral Research|March 9, 2013
3',5'Di-O-trityluridine inhibits in vitro flavivirus replicationTine De Burghgraeve, Barbara Selisko, Suzanne Kaptein, et al.
Journal of Hepatology|December 3, 2015
Stem cell-derived hepatocytes: A novel model for hepatitis E virus replicationNicky Helsen, Yannick Debing, Jan Paeshuyse, et al.
JHEP Reports : Innovation in Hepatology|October 10, 2024
CAM-A-dependent HBV core aggregation induces apoptosis through ANXA1Valerio Taverniti, Laura Meiss-Heydmann, Cloé Gadenne, et al.
Journal of Hepatology|May 14, 2016
Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivityYannick Debing, Christophe Ramière, Kai Dallmeier, et al.
Gastroenterology|March 4, 2014
Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virusYijin Wang, Xinying Zhou, Yannick Debing, et al.
Antiviral Research|January 13, 2017
Biological or pharmacological activation of protein kinase C alpha constrains hepatitis E virus replicationWenshi Wang, Yijin Wang, Yannick Debing, et al.
Gut|March 24, 2016
Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liverIbrahim M Sayed, Lieven Verhoye, Laurence Cocquerel, et al.
Pageof 4